VieCure

We embrace life. We innovate with impact. We empower people to live their best lives.

VCurePrecision™ is the only Artificial Intelligence platform that helps oncologists generate patient-specific treatment plans in real time and at point-of-care using a state-of-the-art clinical inference engine. The platform is a comprehensive, intelligent EMR which includes medical and treatment history, progress notes, prescribing, medication administration record, scheduling, and pharmacy. It also has a mobile patient app to enhance patient engagement, treatment plan adherence, side-effect monitoring, and communication between the patient and the oncology care team.

Watch the video to see how our platform is revolutionizing cancer medicine

At VieCure, we have a solution that is indeed one of a kind in the cancer medicine market - AI for Oncology. It’s multidisciplinary, unbiased, and continuously thinking to provide the most updated patient plan at all times. We can help you improve your clinical quality, enhance your clinical efficiency, mitigate redundant and expensive bolt-on technologies, and stay current with all the changes happening in cancer medicine today.

Contact Us for more information
Trial by Fire: How to Action N-of-1 Clinical Trials for Cancer Patients

Trial by Fire: How to Action N-of-1 Clinical Trials for Cancer Patients

The availability of and correct interpretation of next-generation sequencing results gives the physician the information she or he needs to help the patient be an N-of-1 trial. Decision-support tools make this decision possible at point-of-care; the physician can easily be made aware of the drivers, the potential targeted therapies and have the tools to apply, monitor and manage the patient throughout her or his treatment.

Read More
Factorial Complexity in Cancer Care is Here and Overwhelms!

Factorial Complexity in Cancer Care is Here and Overwhelms!

Genomics-based research is advancing at a pace that it is difficult for any cancer practitioner to interpret, absorb and action. The growing list of biomarker-driven care options compounds the already complex list of factors required for efficient and effective decisions to be made at point of care. Research in cancer care is at an all-time fever pitch. The Scopus database shows more than 1 million peer-reviewed publications and scientific proceedings on the topic of cancer research since 2008. How can any single physician or practice stay current, sift through and select from this vast library, and ultimately make safe sense of it for her/his patients?

Read More
Storm Warning: Old Ways Will Fail in Cancer Care

Storm Warning: Old Ways Will Fail in Cancer Care

Streamlining care with AI decision-support tool. By 2026, there will be ~26 million cancer survivors in America, and more than 2.1 million people who will be newly diagnosed with some form of cancer. Alarmingly, by this timeframe, about 25% of oncologists will be retiring and given current and projected enrollments in medical school, the replacement rate of oncologists will be only 13%.

Read More
Intelligent Mobile App Keeps Cancer Patients Out of the ER

Intelligent Mobile App Keeps Cancer Patients Out of the ER

Intelligent mobile app will improve communications between cancer patients and providers and reduce ER visits. Nonadherence to treatment plans is estimated to account for as much as 50 percent of treatment failures overall, and even for cancer patients, whose lives are on the line, adherence can be as low as 14 percent. Technology can help head-off these negative outcomes. Cancer patients become overwhelmed. The complexity and volume of daily medications and symptom monitoring, while they are experiencing life-altering emotional and physical changes, is the perfect setup for mistakes, oversights, stress and hopelessness. Intelligent mobile technology can break these daily tasks into bite-size pieces and deliver them at the right time, relieving a patient’s responsibility to constantly monitor all facets of their care. 

Read More
CMS decision transformative for cancer care

CMS decision transformative for cancer care

The Centers for Medicare & Medicaid Services’ (CMS) decision to reimburse for Next Generation Sequencing (NGS) for patients with advanced cancer is a major step to realizing personalized cancer treatment. This reimbursement approval fits perfectly with the expanding use of VieCure’s comprehensive platform for precision cancer care that optimally utilizes NGS within its proprietary VCureEyellation™ AI engine.   

Read More

Careers

Interested in joining our team?

At VieCure, we are fighting cancer with a disruptive use of intelligent medicine realized through a fast-paced and demanding technology platform and roadmap.

With great benefits, a flexible work environment and daily challenges in medicine, science and technology, this is the place for those who want to do something that matters.   

See Available Positions

VieCure News

VieCure and Avera Health Confirm Clinical Validation and System-Wide Implementation of AI Platform

VieCure (Greenwood Village, CO) and Avera Health (Sioux Falls, SD) announced today that the VCurePrecision™ platform will be fully implemented across the multi...

Read more

Factorial Complexity in Cancer Care is Here and Overwhelms!

Genomics-based research is advancing at a pace that it is difficult for any cancer practitioner to interpret, absorb and action. The growing list of biomarker-...

Read more

Baptist Health to Improve Cancer Care with VCurePrecision™ AI Platform

VieCure and Baptist Health announced that the VCurePrecision AI platform, which allows clinicians to generate and manage comprehensive, personalized care plans...

Read more

VieCure and Avera Health Announce a Strategic Collaboration Agreement for Precision Medicine

VieCure and Avera Health (Sioux Falls, SD) announce a first-of-its-kind clinical collaboration in personalized medicine for oncology.

Read more

Precision Medicine World Conference

Dr. Howard McLeod from the Moffitt Cancer Center and Dr. Fred Ashbury, Chief Scientific Officer at VieCure, will host a discussion on the challenges and...

Read more

VieCure Appoints Pradip De, PhD, to the Position of Director, Translational Oncology

VieCure announced the appointment of Dr. Pradip De to the position of Director of Translational Oncology. Dr. De is the Senior Scientist and Head of...

Read more

VieCure Announces Appointment of Howard L. McLeod, PharmD, to the Position of Senior Research Advisor in Precision Medicine

VieCure (Greenwood Village, CO) announced the appointment of Dr. Howard McLeod, to the position of Senior Research Advisor in Precision Medicine. McLeod will...

Read more

CMS decision transformative for cancer care

The Centers for Medicare & Medicaid Services’ (CMS) decision to reimburse for Next Generation Sequencing (NGS) for patients with advanced cancer is a major...

Read more

Intelligent Mobile App Keeps Cancer Patients Out of the ER

Intelligent mobile app will improve communications between cancer patients and providers and reduce ER visits. Nonadherence to treatment plans is estimated...

Read more

Storm Warning: Old Ways Will Fail in Cancer Care

Streamlining care with AI decision-support tool. By 2026, there will be ~26 million cancer survivors in America, and more than 2.1 million people who will...

Read more

Trial by Fire: How to Action N-of-1 Clinical Trials for Cancer Patients

The availability of and correct interpretation of next-generation sequencing results gives the physician the information she or he needs to help the patient be...

Read more

#TestMeFirst SURVIVEiT® Patient Awareness Campaign

Cancer research is changing rapidly and it’s vital for patients to have comprehensive genomic profiling of their cancers. With this information, patients can...

Read more